Animal Healthcare Market (2023 - 2033)
Animal Healthcare Market Analysis by Anti-infective Agents, Antibiotics & Antimicrobials, Parasiticides, Vaccines, Hormones & Substitutes, and Nutritional Products from 2024 to 2034
Core Findings
FREE CustomizationAnimal Healthcare Market Outlook (2024 to 2034)
The global animal healthcare market is estimated at US$ 42.87 billion in 2024, as per a new study by Fact.MR. Worldwide demand for animal health products is forecasted to increase at a CAGR of 4.6% and reach a market value of US$ 67.48 billion by the end of 2034.
Growing trend of pet ownership in most countries is set to stimulate the demand for pet healthcare products and veterinary services. Many livestock farmers and pet owners are becoming aware of the pivotal role of preventive healthcare facilities for animals. This is also set to push global demand for animal vaccines, diagnostics, and similar healthcare products.
Key Market Growth Drivers
- Rising occurrence of zoonotic diseases is raising concerns related to human and animal healthcare. This is expected to lead to an increased focus on animal healthcare facilities as a preventive measure against infections.
- Ongoing R&D activities in veterinary pharmaceuticals are estimated to lead to the introduction of improved drugs to prevent animal diseases.
Advancements in diagnostic technologies are forecasted to enhance the ability of healthcare providers to detect and prevent diseases among animals, which is leading to more effective treatment outcomes. Owing to the rising global population, demand for animal-derived products, including eggs, milk, and meat is also increasing. This is projected to result in increased investments in animal healthcare products to improve the productivity and health of livestock.
- Worldwide demand for animal healthcare facilities for companion animals is predicted to increase at 4.5% CAGR and reach a market size of US$ 26.49 billion by the end of 2034.
- Sales of animal healthcare services in East Asia are forecasted to advance at a CAGR of 4.8% and reach US$ 8.89 billion by 2034.
- Veterinary hospitals held 32.2% share of global market revenue in 2023.
Adoption of more efficient digital technology in pet health and livestock is estimated to contribute to market growth. Predictive monitoring tools, including wearables and sound detection tools, enable precision care for animals.
| Report Attributes | Details |
|---|---|
| Animal Healthcare Market Size (2024E) | US$ 42.87 Billion |
| Forecasted Market Value (2034F) | US$ 67.48 Billion |
| Global Market Growth Rate (2024 to 2034) | 4.6% CAGR |
| North America Market Share (2024E) | 33.5% |
| Japan Market Value (2034F) | US$ 2.7 Billion |
| Canada Market Value (2034F) | US$ 3.22 Billion |
| Farm Animals Segment Value (2034F) | US$ 41 Billion |
| Companion Animals Segment Share (2024E) | 39.9% |
| Key Companies Profiled | Bayer AG; Virbac SA; Boehringer Ingelheim GmbH; Zoetis, Inc.; Intas Pharmaceuticals Ltd.; Hester Biosciences Ltd.; Merck Animal Health; Ceva Sante Animale; Elanco; Alivira Animal Health Limited; Zydus Animal Health; Vetoquinol S.A.; Norbrook Laboratories Limited; Dechra Pharmaceuticals PLC; Phibro Animal Health Corporation; Norbrook Laboratories, Inc. |
What’s Influencing Demand for Animal Healthcare Solutions?
“Automated Injection Devices Ensuring Efficient and Timely Vaccination”
The precision and effectiveness of mass immunization are improved with the development of new vaccine platforms. Newly produced automated injection devices and oral vaccinations enable effective protection in aquaculture and avoid manual injections that are time-consuming.
Farmers can avail protection facilities that are customized to their environment and livestock thanks to autogenous vaccines. If a veterinarian suspects that a herd may be harboring a disease and conventional immunization is insufficient, they can consider seeking autogenous vaccines.
Animal healthcare facilities can offer customized solutions according to specific virus strains with the use of a herd culture sample, which can help in the protection of farm animals that are not infected.
“Regulatory Flexibility Speeding Up Vaccine Development Process”
Regulatory flexibility is forecasted to speed up the process of vaccine development as well as delivery. An elementary vaccine technology can be approved initially, which further allows subsequent evaluation to focus on the unique and innovative features of vaccine application.
Promotion strategies by businesses are crucial for the submission of samples for vaccine development. This is predicted to improve flexibility and agility in addressing disease threats in several geographical locations and push the global animal healthcare market size up at a faster pace.
Regulators are projected to improve the options to demonstrate safety and efficacy to minimize the count of study animals required for creating standards for new testing procedures, including in vitro testing and others. This is predicted to eliminate the need for pointless batch safety testing.
What Challenges are Expected to Affect Market Growth?
“Short Patent Protection Period and Laborious Regulatory Approval Activities”
More than 50 different animal species need the administration of health products and veterinary medicines for disease diagnosis, treatment, and prevention. It is difficult to develop vaccines that can operate in diverse contexts, and therefore, it becomes pivotal to adhere to several regulatory frameworks. Moreover, it takes longer to use any drug for animal treatment, and that is why animal healthcare market trends are quite different from most other businesses.
Potential for a return on investment in the pharmaceutical industry is constrained by time, unless the product is safeguarded by a patent, especially in the context of livestock. In Europe, companies benefit from a ten-year data protection period after obtaining approval to sell a novel product.
In the United States, data protection is in place for five years only, and after this, a process needs to be followed for recovery for setting international standards. Manufacturers who want to export products need to establish MRLs (maximum residue levels) before product employment. It means that, before getting a return on investment, manufacturers lose their exclusivity protection due to time limitations.
The animal health sector adopts GMP (good manufacturing practice) regulations that are specifically designed for human health. Without modifications in these practices, an animal health product can be subject to pointless regulations that make production unprofitable.
What Strategies are Start-ups Incorporating to Establish Themselves in the Market?
“Focus on Digitalization Enabling Precision Care for Animals”
Veterinary healthcare is evolving rapidly with technological advancements, including artificial intelligence, big data, biotech, cloud computing, and genomics. New entrants in the industry have the opportunity to invest in technology that is anticipated to facilitate precise care for animals. Technologies such as sound detection tools, wearables, and smart tags are among the popular choices that can enhance the profit margin for start-ups.
Country-wise Insights
Asia Pacific held a significant animal healthcare market share in 2023 due to the increasing number of veterinary hospitals, polyclinics, and healthcare institutions in the region. In addition, collaborations between these organizations with animal healthcare centers and trusts are also offering growth opportunities to players.
What is Driving Demand for Animal Healthcare Facilities in the United States?
“Growth of Livestock Sector and Rising Adoption of Companion Animals”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 11.09 Billion |
| Growth Rate (2024 to 2034) | 4.6% CAGR |
| Projected Value (2034F) | US$ 17.31 Billion |
The United States is predicted to account for 78.12% share of the North American market in 2034. The increased production of dairy and meat products for international and domestic consumers is largely dependent on healthy livestock. It offers Americans wholesome pocket-friendly and healthy food and benefits the American economy.
- As per the data provided by the American Health Institute, about 400 million pets, including dogs, cats, fish, birds, and horses, are owned by around 67% of American homes. Ranchers and farmers employ medication for the well-being of animals used in food cultivation to safeguard food supply and public health.
Why are Animal Healthcare Providers Eyeing Germany?
“Supportive Guidelines and Reimbursement Policies”
Germany held 19% share of the Europe market in 2023. According to a study by Fact.MR, a market research and competitive intelligence provider, animal health is one of the key concerns among many Germans. This concern is acknowledged due to its implications for both food safety and public health. There are financial repercussions associated with animal health epidemics, along with the consideration of the well-being of the animals involved.
The government of Germany plays a significant role in protecting animals’ health with effective protection policies and quick responses against disease epidemics.
What is Set to Position China at the Forefront in the East Asian Market?
“Increasing Investments in Animal Healthcare Facilities”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 2.42 Billion |
| Growth Rate (2024 to 2034) | 5.1% CAGR |
| Projected Value (2034F) | US$ 3.96 Billion |
The regulatory environment in China is undergoing significant changes. Chinese authorities and executives are making the policy-making process transparent by involving businesses in the process. Several multinational companies are establishing their manufacturing operations and R&D facilities in China. This is attributed to the support provided to the veterinary pharmaceutical sector in the country.
Category-wise Insights
Farm animals are predicted to account for 60.8% share of global market revenue in 2034 owing to increased concerns about sustainability and food safety among government healthcare organizations. The long-term goal of sustainability is possible with a concentration on livestock animal care.
Why Do Farm Animals Account for a Leading Market Share?
“High Demand for Animal-based Products for Efficient Farm Animal Management”
| Attribute | Farm Animals |
|---|---|
| Segment Value (2024E) | US$ 25.75 Billion |
| Growth Rate (2024 to 2034) | 4.8% CAGR |
| Projected Value (2034F) | US$ 41 Billion |
Farm animals held 60% share of the global market in 2023. Animal husbandry is pivotal to human nutrition. The emergence of the middle-class population in developing countries and their new consumption patterns are predicted to push the demand for animal protein. Some new difficulties can be experienced in disease control due to growth in animal production. Therefore, the management of farm animals is crucial because of the growing need for animal-based products.
Which Route of Administration is Most Popular in Animal Healthcare?
“Physical and Chemical Stability of Oral Route of Administration”
The oral route of administration held 44.5% share of global market revenue in 2023. Regular vaccines and oral treatments are provided by many farmers to their respective cattle and horses. The majority of typical medications that are given to cats and dogs are chewable and traditional pills. Compared to liquid forms, tablets are more physically and chemically stable, which is predicted to contribute to their increased demand.
Competition Landscape
Companies are incorporating multiple strategies to achieve several purposes, including efficient management of supply chain systems, ensuring quality control of products, and new developments. New launches, collaborations, etc., are some organic and inorganic strategies adopted by companies to drive their animal healthcare market growth.
For instance :
- In April 2021, Hester Biosciences started developing research-based herbal products for pigs, goats, sheep, cattle, and poultry.
Key players in the animal healthcare market are Bayer AG, Virbac SA, Boehringer Ingelheim GmbH, Zoetis, Inc., Intas Pharmaceuticals Ltd., Hester Biosciences Ltd., Merck Animal Health, Ceva Sante Animale, Elanco, Alivira Animal Health Limited, Zydus Animal Health, Vetoquinol S.A., Norbrook Laboratories Limited, Dechra Pharmaceuticals PLC, Phibro Animal Health Corporation, and Norbrook Laboratories, Inc.
Segmentation of Animal Healthcare Market Research
-
By Drug Type :
- Anti-infective Agents
- Antibiotics & Antimicrobials
- Parasiticides
- Vaccines
- Hormones & Substitutes
- Nutritional Products
-
By Animal Type :
- Companion Animals
- Farm Animals
-
By Route of Administration :
- Oral
- Parenteral
- Topical
-
By Distribution Channel :
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
-
By Region :
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Pricing Analysis
- 5. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
- 6. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034), by Drug Type
- 6.1. Anti-infective Agents
- 6.2. Antibiotics & Antimicrobials
- 6.3. Parasiticides
- 6.4. Vaccines
- 6.5. Hormones & Substitutes
- 6.6. Nutritional Products
- 7. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034), by Animal Type
- 7.1. Companion Animals
- 7.2. Farm Animals
- 8. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034), by Route of Administration
- 8.1. Oral
- 8.2. Parenteral
- 8.3. Topical
- 9. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034), by Distribution Channel
- 9.1. Veterinary Hospitals
- 9.2. Veterinary Clinics
- 9.3. Pharmacies & Drug Stores
- 10. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034), by Region
- 10.1. North America
- 10.2. Europe
- 10.3. East Asia
- 10.4. South Asia
- 10.5. Latin America
- 10.6. Middle East & Africa (MEA)
- 10.7. Oceania
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia Market Analysis and Forecast
- 15. Latin America Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Oceania Market Analysis and Forecast
- 18. Global Market Analysis Key Countries
- 19. Competition Landscape
- 20. Competition Analysis
- 20.1. Bayer AG
- 20.2. Virbac SA
- 20.3. Boehringer Ingelheim GmbH
- 20.4. Zoetis, Inc.
- 20.5. Intas Pharmaceuticals Ltd.
- 20.6. Hester Biosciences Ltd.
- 20.7. Merck Animal Health
- 20.8. Ceva Sante Animale
- 20.9. Elanco
- 20.10. Alivira Animal Health Limited
- 20.11. Zydus Animal Health
- 20.12. Vetoquinol S.A.
- 20.13. Norbrook Laboratories Limited
- 20.14. Dechra Pharmaceuticals PLC
- 20.15. Phibro Animal Health Corporation
- 20.16. Norbrook Laboratories, Inc.
- 21. Appendix
- 22. Definitions of Analytical Frameworks
- 23. Sources and References
List Of Table
Table 01: Global Market by Drug Type, 2018 to 2034
Table 02: Global Market Value (US$ Mn), by Drug Type, 2018 to 2034
Table 03: Global Market by Animal Type, 2018 to 2034
Table 04: Global Market Value (US$ Mn), by Animal Type, 2018 to 2034
Table 05: Global Market by Route of Administration, 2018 to 2034
Table 06: Global Market Value (US$ Mn), by Route of Administration, 2018 to 2034
Table 07: Global Market by Distribution Channel, 2018 to 2034
Table 08: Global Market Value (US$ Mn), by Distribution Channel, 2018 to 2034
Table 09: Global Market by Region, 2018 to 2034
Table 10: Global Market Value (US$ Mn), by Region, 2018 to 2034
Table 11: North America Market by Drug Type, 2018 to 2034
Table 12: North America Market Value (US$ Mn), by Drug Type, 2018 to 2034
Table 13: North America Market by Animal Type, 2018 to 2034
Table 14: North America Market Value (US$ Mn), by Animal Type, 2018 to 2034
Table 15: North America Market by Route of Administration, 2018 to 2034
Table 16: North America Market Value (US$ Mn), by Route of Administration, 2018 to 2034
Table 17: North America Market by Distribution Channel, 2018 to 2034
Table 18: North America Market Value (US$ Mn), by Distribution Channel, 2018 to 2034
Table 19: North America Market by Country, 2018 to 2034
Table 20: North America Market Value (US$ Mn), by Country, 2018 to 2034
Table 21: Europe Market by Drug Type, 2018 to 2034
Table 22: Europe Market Value (US$ Mn), by Drug Type, 2018 to 2034
Table 23: Europe Market by Animal Type, 2018 to 2034
Table 24: Europe Market Value (US$ Mn), by Animal Type, 2018 to 2034
Table 25: Europe Market by Route of Administration, 2018 to 2034
Table 26: Europe Market Value (US$ Mn), by Route of Administration, 2018 to 2034
Table 27: Europe Market by Distribution Channel, 2018 to 2034
Table 28: Europe Market Value (US$ Mn), by Distribution Channel, 2018 to 2034
Table 29: Europe Market by Country, 2018 to 2034
Table 30: Europe Market Value (US$ Mn), by Country, 2018 to 2034
Table 31: East Asia Market by Drug Type, 2018 to 2034
Table 32: East Asia Market Value (US$ Mn), by Drug Type, 2018 to 2034
Table 33: East Asia Market by Animal Type, 2018 to 2034
Table 34: East Asia Market Value (US$ Mn), by Animal Type, 2018 to 2034
Table 35: East Asia Market by Route of Administration, 2018 to 2034
Table 36: East Asia Market Value (US$ Mn), by Route of Administration, 2018 to 2034
Table 37: East Asia Market by Distribution Channel, 2018 to 2034
Table 38: East Asia Market Value (US$ Mn), by Distribution Channel, 2018 to 2034
Table 39: East Asia Market by Country, 2018 to 2034
Table 40: East Asia Market Value (US$ Mn), by Country, 2018 to 2034
Table 41: South Asia Market by Drug Type, 2018 to 2034
Table 42: South Asia Market Value (US$ Mn), by Drug Type, 2018 to 2034
Table 43: South Asia Market by Animal Type, 2018 to 2034
Table 44: South Asia Market Value (US$ Mn), by Animal Type, 2018 to 2034
Table 45: South Asia Market by Route of Administration, 2018 to 2034
Table 46: South Asia Market Value (US$ Mn), by Route of Administration, 2018 to 2034
Table 47: South Asia Market by Distribution Channel, 2018 to 2034
Table 48: South Asia Market Value (US$ Mn), by Distribution Channel, 2018 to 2034
Table 49: South Asia Market by Country, 2018 to 2034
Table 50: South Asia Market Value (US$ Mn), by Country, 2018 to 2034
Table 51: Latin America Market by Drug Type, 2018 to 2034
Table 52: Latin America Market Value (US$ Mn), by Drug Type, 2018 to 2034
Table 53: Latin America Market by Animal Type, 2018 to 2034
Table 54: Latin America Market Value (US$ Mn), by Animal Type, 2018 to 2034
Table 55: Latin America Market by Route of Administration, 2018 to 2034
Table 56: Latin America Market Value (US$ Mn), by Route of Administration, 2018 to 2034
Table 57: Latin America Market by Distribution Channel, 2018 to 2034
Table 58: Latin America Market Value (US$ Mn), by Distribution Channel, 2018 to 2034
Table 59: Latin America Market by Country, 2018 to 2034
Table 60: Latin America Market Value (US$ Mn), by Country, 2018 to 2034
Table 61: Middle East and Africa Market by Drug Type, 2018 to 2034
Table 62: Middle East and Africa Market Value (US$ Mn), by Drug Type, 2018 to 2034
Table 63: Middle East and Africa Market by Animal Type, 2018 to 2034
Table 64: Middle East and Africa Market Value (US$ Mn), by Animal Type, 2018 to 2034
Table 65: Middle East and Africa Market by Route of Administration, 2018 to 2034
Table 66: Middle East and Africa Market Value (US$ Mn), by Route of Administration, 2018 to 2034
Table 67: Middle East and Africa Market by Distribution Channel, 2018 to 2034
Table 68: Middle East and Africa Market Value (US$ Mn), by Distribution Channel, 2018 to 2034
Table 69: Middle East and Africa Market by Country, 2018 to 2034
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2018 to 2034
Table 71: Oceania Market by Drug Type, 2018 to 2034
Table 72: Oceania Market Value (US$ Mn), by Drug Type, 2018 to 2034
Table 73: Oceania Market by Animal Type, 2018 to 2034
Table 74: Oceania Market Value (US$ Mn), by Animal Type, 2018 to 2034
Table 75: Oceania Market by Route of Administration, 2018 to 2034
Table 76: Oceania Market Value (US$ Mn), by Route of Administration, 2018 to 2034
Table 77: Oceania Market by Distribution Channel, 2018 to 2034
Table 78: Oceania Market Value (US$ Mn), by Distribution Channel, 2018 to 2034
Table 79: Oceania Market by Country, 2018 to 2034
Table 80: Oceania Market Value (US$ Mn), by Country, 2018 to 2034
List Of Figures
Fig 01: Global Market Value (US$) and Y-o-Y Growth, 2018 to 2034
Fig 02: Global Absolute $ Historical Market (2018 to 2023) and Absolute $ Opportunity (2024 to 2034), US$ Mn
Fig 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Fig 04: Global Market Incremental $ Opportunity (US$ Thousand), 2024 to 2034
Fig 05: Global Market Share, By Drug Type – 2024 to 2034
Fig 06: Global Market Y-o-Y Growth Projections, By Drug Type – 2024 to 2034
Fig 07: Global Market Attractiveness Index, By Drug Type – 2024 to 2034
Fig 08: Global Market Share, By Animal Type – 2024 to 2034
Fig 09: Global Market Y-o-Y Growth Projections, By Animal Type – 2024 to 2034
Fig 10: Global Market Attractiveness Index, By Animal Type – 2024 to 2034
Fig 11: Global Market Share, By Route of Administration – 2024 to 2034
Fig 12: Global Market Y-o-Y Growth Projections, By Route of Administration – 2024 to 2034
Fig 13: Global Market Attractiveness Index, By Route of Administration – 2024 to 2034
Fig 14: Global Market Share, By Distribution Channel – 2024 to 2034
Fig 15: Global Market Y-o-Y Growth Projections, By Distribution Channel – 2024 to 2034
Fig 16: Global Market Attractiveness Index, By Distribution Channel – 2024 to 2034
Fig 17: Global Market Share, by Region – 2024 to 2034
Fig 18: Global Market Y-o-Y Growth Projections, by Region – 2024 to 2034
Fig 19: Global Market Attractiveness Index, by Region – 2024 to 2034
Fig 20: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 21: North America Market Share, By Drug Type – 2024 to 2034
Fig 22: North America Market Y-o-Y Growth Projections, By Drug Type – 2024 to 2034
Fig 23: North America Market Attractiveness Index, By Drug Type – 2024 to 2034
Fig 24: North America Market Share, By Animal Type – 2024 to 2034
Fig 25: North America Market Y-o-Y Growth Projections, By Animal Type – 2024 to 2034
Fig 26: North America Market Attractiveness Index, By Animal Type – 2024 to 2034
Fig 27: North America Market Share, By Route of Administration – 2024 to 2034
Fig 28: North America Market Y-o-Y Growth Projections, By Route of Administration – 2024 to 2034
Fig 29: North America Market Attractiveness Index, By Route of Administration – 2024 to 2034
Fig 30: North America Market Share, By Distribution Channel – 2024 to 2034
Fig 31: North America Market Y-o-Y Growth Projections, By Distribution Channel – 2024 to 2034
Fig 32: North America Market Attractiveness Index, By Distribution Channel – 2024 to 2034
Fig 33: North America Market Share, By Country – 2024 to 2034
Fig 34: North America Market Y-o-Y Growth Projections, By Country – 2024 to 2034
Fig 35: North America Market Attractiveness Index, By Country – 2024 to 2034
Fig 36: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 37: Europe Market Share, By Drug Type – 2024 to 2034
Fig 38: Europe Market Y-o-Y Growth Projections, By Drug Type – 2024 to 2034
Fig 39: Europe Market Attractiveness Index, By Drug Type – 2024 to 2034
Fig 40: Europe Market Share, By Animal Type – 2024 to 2034
Fig 41: Europe Market Y-o-Y Growth Projections, By Animal Type – 2024 to 2034
Fig 42: Europe Market Attractiveness Index, By Animal Type – 2024 to 2034
Fig 43: Europe Market Share, By Route of Administration – 2024 to 2034
Fig 44: Europe Market Y-o-Y Growth Projections, By Route of Administration – 2024 to 2034
Fig 45: Europe Market Attractiveness Index, By Route of Administration – 2024 to 2034
Fig 46: Europe Market Share, By Distribution Channel – 2024 to 2034
Fig 47: Europe Market Y-o-Y Growth Projections, By Distribution Channel – 2024 to 2034
Fig 48: Europe Market Attractiveness Index, By Distribution Channel – 2024 to 2034
Fig 49: Europe Market Share, By Country – 2024 to 2034
Fig 50: Europe Market Y-o-Y Growth Projections, By Country – 2024 to 2034
Fig 51: Europe Market Attractiveness Index, By Country – 2024 to 2034
Fig 52: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 53: East Asia Market Share, By Drug Type – 2024 to 2034
Fig 54: East Asia Market Y-o-Y Growth Projections, By Drug Type – 2024 to 2034
Fig 55: East Asia Market Attractiveness Index, By Drug Type – 2024 to 2034
Fig 56: East Asia Market Share, By Animal Type – 2024 to 2034
Fig 57: East Asia Market Y-o-Y Growth Projections, By Animal Type – 2024 to 2034
Fig 58: East Asia Market Attractiveness Index, By Animal Type – 2024 to 2034
Fig 59: East Asia Market Share, By Route of Administration – 2024 to 2034
Fig 60: East Asia Market Y-o-Y Growth Projections, By Route of Administration – 2024 to 2034
Fig 61: East Asia Market Attractiveness Index, By Route of Administration – 2024 to 2034
Fig 62: East Asia Market Share, By Distribution Channel – 2024 to 2034
Fig 63: East Asia Market Y-o-Y Growth Projections, By Distribution Channel – 2024 to 2034
Fig 64: East Asia Market Attractiveness Index, By Distribution Channel – 2024 to 2034
Fig 65: East Asia Market Share, By Country – 2024 to 2034
Fig 66: East Asia Market Y-o-Y Growth Projections, By Country – 2024 to 2034
Fig 67: East Asia Market Attractiveness Index, By Country – 2024 to 2034
Fig 68: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 69: South Asia Market Share, By Drug Type – 2024 to 2034
Fig 70: South Asia Market Y-o-Y Growth Projections, By Drug Type – 2024 to 2034
Fig 71: South Asia Market Attractiveness Index, By Drug Type – 2024 to 2034
Fig 72: South Asia Market Share, By Animal Type – 2024 to 2034
Fig 73: South Asia Market Y-o-Y Growth Projections, By Animal Type – 2024 to 2034
Fig 74: South Asia Market Attractiveness Index, By Animal Type – 2024 to 2034
Fig 75: South Asia Market Share, By Route of Administration – 2024 to 2034
Fig 76: South Asia Market Y-o-Y Growth Projections, By Route of Administration – 2024 to 2034
Fig 77: South Asia Market Attractiveness Index, By Route of Administration – 2024 to 2034
Fig 78: South Asia Market Share, By Distribution Channel – 2024 to 2034
Fig 78: South Asia Market Y-o-Y Growth Projections, By Distribution Channel – 2024 to 2034
Fig 80: South Asia Market Attractiveness Index, By Distribution Channel – 2024 to 2034
Fig 81: South Asia Market Share, By Country – 2024 to 2034
Fig 82: South Asia Market Y-o-Y Growth Projections, By Country – 2024 to 2034
Fig 83: South Asia Market Attractiveness Index, By Country – 2024 to 2034
Fig 84: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 85: Latin America Market Share, By Drug Type – 2024 to 2034
Fig 86: Latin America Market Y-o-Y Growth Projections, By Drug Type – 2024 to 2034
Fig 87: Latin America Market Attractiveness Index, By Drug Type – 2024 to 2034
Fig 88: Latin America Market Share, By Animal Type – 2024 to 2034
Fig 89: Latin America Market Y-o-Y Growth Projections, By Animal Type – 2024 to 2034
Fig 90: Latin America Market Attractiveness Index, By Animal Type – 2024 to 2034
Fig 91: Latin America Market Share, By Route of Administration – 2024 to 2034
Fig 92: Latin America Market Y-o-Y Growth Projections, By Route of Administration – 2024 to 2034
Fig 93: Latin America Market Attractiveness Index, By Route of Administration – 2024 to 2034
Fig 94: Latin America Market Share, By Distribution Channel – 2024 to 2034
Fig 95: Latin America Market Y-o-Y Growth Projections, By Distribution Channel – 2024 to 2034
Fig 96: Latin America Market Attractiveness Index, By Distribution Channel – 2024 to 2034
Fig 97: Latin America Market Share, By Country – 2024 to 2034
Fig 98: Latin America Market Y-o-Y Growth Projections, By Country – 2024 to 2034
Fig 99: Latin America Market Attractiveness Index, By Country – 2024 to 2034
Fig 100: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 101: MEA Market Share, By Drug Type – 2024 to 2034
Fig 102: MEA Market Y-o-Y Growth Projections, By Drug Type – 2024 to 2034
Fig 103: MEA Market Attractiveness Index, By Drug Type – 2024 to 2034
Fig 104: MEA Market Share, By Animal Type – 2024 to 2034
Fig 105: MEA Market Y-o-Y Growth Projections, By Animal Type – 2024 to 2034
Fig 106: MEA Market Attractiveness Index, By Animal Type – 2024 to 2034
Fig 107: MEA Market Share, By Route of Administration – 2024 to 2034
Fig 108: MEA Market Y-o-Y Growth Projections, By Route of Administration – 2024 to 2034
Fig 109: MEA Market Attractiveness Index, By Route of Administration – 2024 to 2034
Fig 110: MEA Market Share, By Distribution Channel – 2024 to 2034
Fig 111: MEA Market Y-o-Y Growth Projections, By Distribution Channel – 2024 to 2034
Fig 112: MEA Market Attractiveness Index, By Distribution Channel – 2024 to 2034
Fig 113: MEA Market Share, By Country – 2024 to 2034
Fig 114: MEA Market Y-o-Y Growth Projections, By Country – 2024 to 2034
Fig 115: MEA Market Attractiveness Index, By Country – 2024 to 2034
Fig 116: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 117: Oceania Market Share, By Drug Type – 2024 to 2034
Fig 118: Oceania Market Y-o-Y Growth Projections, By Drug Type – 2024 to 2034
Fig 119: Oceania Market Attractiveness Index, By Drug Type – 2024 to 2034
Fig 120: Oceania Market Share, By Animal Type – 2024 to 2034
Fig 121: Oceania Market Y-o-Y Growth Projections, By Animal Type – 2024 to 2034
Fig 122: Oceania Market Attractiveness Index, By Animal Type – 2024 to 2034
Fig 123: Oceania Market Share, By Route of Administration – 2024 to 2034
Fig 124: Oceania Market Y-o-Y Growth Projections, By Route of Administration – 2024 to 2034
Fig 125: Oceania Market Attractiveness Index, By Route of Administration – 2024 to 2034
Fig 126: Oceania Market Share, By Distribution Channel – 2024 to 2034
Fig 127: Oceania Market Y-o-Y Growth Projections, By Distribution Channel – 2024 to 2034
Fig 128: Oceania Market Attractiveness Index, By Distribution Channel – 2024 to 2034
Fig 129: Oceania Market Share, By Country – 2024 to 2034
Fig 130: Oceania Market Y-o-Y Growth Projections, By Country – 2024 to 2034
Fig 131: Oceania Market Attractiveness Index, By Country – 2024 to 2034
Fig 132: United States Market share by Drug Type, 2023
Fig 133: United States Market share by Animal Type, 2023
Fig 134: United States Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 135: United States Market Share by Distribution Channel, 2023
Fig 136: Canada Market share by Drug Type, 2023
Fig 137: Canada Market share by Animal Type, 2023
Fig 138: Canada Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 139: Canada Market Share by Distribution Channel, 2023
Fig 140: Germany Market share by Drug Type, 2023
Fig 141: Germany Market share by Animal Type, 2023
Fig 142: Germany Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 143: Germany Market Share by Distribution Channel, 2023
Fig 144: United Kingdom Market share by Drug Type, 2023
Fig 145: United Kingdom Market share by Animal Type, 2023
Fig 146: United Kingdom Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 147: United Kingdom Market Share by Distribution Channel, 2023
Fig 148: France Market share by Drug Type, 2023
Fig 149: France Market share by Animal Type, 2023
Fig 150: France Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 151: France Market Share by Distribution Channel, 2023
Fig 152: Russia Market share by Drug Type, 2023
Fig 153: Russia Market share by Animal Type, 2023
Fig 154: Russia Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 155: Russia Market Share by Distribution Channel, 2023
Fig 156: Spain Market share by Drug Type, 2023
Fig 157: Spain Market share by Animal Type, 2023
Fig 158: Spain Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 159: Spain Market Share by Distribution Channel, 2023
Fig 160: Italy Market share by Drug Type, 2023
Fig 161: Italy Market share by Animal Type, 2023
Fig 162: Italy Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 163: Italy Market Share by Distribution Channel, 2023
Fig 164: China Market share by Drug Type, 2023
Fig 165: China Market share by Animal Type, 2023
Fig 166: China Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 167: China Market Share by Distribution Channel, 2023
Fig 168: Japan Market share by Drug Type, 2023
Fig 169: Japan Market share by Animal Type, 2023
Fig 170: Japan Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 171: Japan Market Share by Distribution Channel, 2023
Fig 172: South Korea Market share by Drug Type, 2023
Fig 173: South Korea Market share by Animal Type, 2023
Fig 174: South Korea Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 175: South Korea Market Share by Distribution Channel, 2023
Fig 176: India Market share by Drug Type, 2023
Fig 177: India Market share by Animal Type, 2023
Fig 178: India Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 179: India Market Share by Distribution Channel, 2023
Fig 180: Singapore Market share by Drug Type, 2023
Fig 181: Singapore Market share by Animal Type, 2023
Fig 182: Singapore Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 183: Singapore Market Share by Distribution Channel, 2023
Fig 184: Indonesia Market share by Drug Type, 2023
Fig 185: Indonesia Market share by Animal Type, 2023
Fig 186: Indonesia Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 187: Indonesia Market Share by Distribution Channel, 2023
Fig 188: Thailand Market share by Drug Type, 2023
Fig 189: Thailand Market share by Animal Type, 2023
Fig 190: Thailand Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 191: Thailand Market Share by Distribution Channel, 2023
Fig 192: Brazil Market share by Drug Type, 2023
Fig 193: Brazil Market share by Animal Type, 2023
Fig 194: Brazil Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 195: Brazil Market Share by Distribution Channel, 2023
Fig 196: Mexico Market share by Drug Type, 2023
Fig 197: Mexico Market share by Animal Type, 2023
Fig 198: Mexico Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 199: Mexico Market Share by Distribution Channel, 2023
Fig 200: Turkey Market share by Drug Type, 2023
Fig 201: Turkey Market share by Animal Type, 2023
Fig 202: Turkey Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 203: Turkey Market Share by Distribution Channel, 2023
Fig 204: GCC Countries Market share by Drug Type, 2023
Fig 205: GCC Countries Market share by Animal Type, 2023
Fig 206: GCC Countries Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 207: GCC Countries Market Share by Distribution Channel, 2023
Fig 208: South Africa Market share by Drug Type, 2023
Fig 209: South Africa Market share by Animal Type, 2023
Fig 210: South Africa Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 211: South Africa Market Share by Distribution Channel, 2023
Fig 212: Australia Market share by Drug Type, 2023
Fig 213: Australia Market share by Animal Type, 2023
Fig 214: Australia Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 215: Australia Market Share by Distribution Channel, 2023
Fig 216: New Zealand Market share by Drug Type, 2023
Fig 217: New Zealand Market share by Animal Type, 2023
Fig 218: New Zealand Market Value (US$ Mn) and Forecast 2024 to 2034
Fig 219: New Zealand Market Share by Distribution Channel, 2023
- FAQs -
How big is the animal healthcare market expected to be in 2024?
The global animal healthcare market is estimated at US$ 42.87 billion in 2024.
What share of the global market does North America hold?
North America is estimated to account for 33.5% share of the global market in 2024.
What is the forecasted size of the animal healthcare market by 2034?
The market for animal healthcare is set to reach US$ 67.48 billion by the end of 2034.
At what rate is the demand for animal healthcare solutions projected to increase?
Demand for animal healthcare solutions is forecasted to rise at 4.6% CAGR from 2024 to 2034.
What is the predicted sales value of animal healthcare solutions in Canada?
Sales of animal healthcare solutions in Canada are forecasted to reach US$ 3.22 billion by 2034-end.
What is the forecasted valuation of the market in Japan for 2034?
The market in Japan is projected to reach US$ 2.7 billion by the end of 2034.
Related Reports
Animal Healthcare Market